Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline

NEXT STORY
Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual
PREV STORY
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

AUSTIN, Texas, May 29, 2018 (GLOBE NEWSWIRE) -- Savara, Inc. (NASDAQ:SVRA), an orphan lung ...

author_avatar
NASDAQ Market News

Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress

Fluidigm Posts Sequential and Year-Over-Year Quarterly Revenue Growth 2017 Highlights Include Launch of Hyperion ...

author_avatar
NASDAQ Market News

Sublimity Therapeutics Appoints Jesse W. Hall as Chief Medical Officer

DUBLIN, Ireland, July 30, 2018 (GLOBE NEWSWIRE) -- Sublimity Therapeutics, a specialty pharmaceutical company ...

author_avatar
NASDAQ Market News